TrialBMC infectious diseases2017

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Yu Bin Seo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.